Table 1.
RTKs genes for screen
Gene symbol | Official Full Name | Inhibitor | Associated with cardiotoxicity (Ref) |
---|---|---|---|
ERBB4 | v-erb-a erythroblastic leukemia viral oncogene homolog 4 | NA | NA |
MST1R | macrophage stimulating 1 receptor | NA | NA |
RYK | receptor-like tyrosine kinase | NA | NA |
KDR | kinase insert domain receptor | sorafenib/sunitinib | [8,32] |
NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | NA | NA |
STYK1 | serine/threonine/tyrosine kinase 1 | NA | NA |
EPHA3 | EPH receptor A3 | NA | NA |
FLT1 | fms-related tyrosine kinase 1 | sorafenib/sunitinib | [8,32] |
FGFR1 | fibroblast growth factor receptor 1 | PD-173074 | NA |
AXL | AXL receptor tyrosine kinase | NA | NA |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | NA | NA |
TEK | TEK tyrosine kinase, endothelial | NA | NA |
EGFR | epidermal growth factor receptor | erlotinib/gefitinib/lapatinib | [1,8] |
ROR2 | receptor tyrosine kinase-like orphan receptor 2 | NA | NA |
FLT3 | fms-related tyrosine kinase 3 | sorafenib/sunitinib | [8,32] |
ALK | anaplastic lymphoma receptor tyrosine kinase | crizotinib | NA |
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | AZD8931 | NA |
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2 | Lapatinib | [1,32] |
INSRR | insulin receptor-related receptor | NA | NA |
EPHA6 | EPH receptor A6 | NA | NA |
EPHA5 | EPH receptor A5 | NA | NA |
EPHA7 | EPH receptor A7 | NA | NA |
FGFR3 | fibroblast growth factor receptor 3 | Linifanib/AZD4547 | NA |
MUSK | muscle, skeletal, receptor tyrosine kinase | NA | NA |
RET | ret proto-oncogene | Motesanib | [8,32] |
IGF1R | insulin-like growth factor 1 receptor | NVP-ADW742 | NA |
CSF1R | colony stimulating factor 1 receptor | Linifanib | [8] |
MET | met proto-oncogene (hepatocyte growth factor receptor) | AMG-208 | NA |
EPHA2 | EPH receptor A2 | NA | NA |
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | Dasatinib/nilotinib | [1,8,32] |
INSR | insulin receptor | NA | NA |
FGFR2 | fibroblast growth factor receptor 2 | AZD4547 | NA |
PTK7 | PTK7 protein tyrosine kinase 7 | NA | NA |
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | nilotinib/sorafenib | [1,8,32] |
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | Dasatinib/sunitinib | [1,8,32] |
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | NA | NA |
DDR2 | discoidin domain receptor tyrosine kinase 2 | NA | NA |
DDR1 | discoidin domain receptor tyrosine kinase 1 | NA | NA |
LTK | leukocyte receptor tyrosine kinase | NA | NA |
EPHB3 | EPH receptor B3 | NA | NA |
FGFR4 | fibroblast growth factor receptor 4 | BGJ398 | NA |
EPHA8 | EPH receptor A8 | NA | NA |
NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | NA | NA |
FLT4 | fms-related tyrosine kinase 4 | sunitinib | [8,32] |
EPHB4 | EPH receptor B4 | NA | NA |
LMTK2 | lemur tyrosine kinase 2 | NA | NA |
EPHA1 | EPH receptor A1 | NA | NA |
AATK | apoptosis-associated tyrosine kinase | NA | NA |
MERTK | c-mer proto-oncogene tyrosine kinase | NA | NA |
TYRO3 | TYRO3 protein tyrosine kinase | BMS 777607 | NA |
ROS1 | c-ros oncogene 1, receptor tyrosine kinase | NA | NA |
EPHA4 | EPH receptor A4 | NA | NA |
EPHB6 | EPH receptor B6 | NA | NA |
Ref, reference; NA, not available.